Reply-On dissonances, Helicobacter pylori and NSAIDs

This publication has 20 references indexed in Scilit:

• Reply -Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users
  Alimentary Pharmacology & Therapeutics, 2000
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study
  Gastroenterology, 1999
• Triple therapy for Helicobacter pylori eradication is more effective than long‐term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long‐term follow‐up study
  Alimentary Pharmacology & Therapeutics, 1999
• Eradication of H. Pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: A prospective randomizd study
  Gastroenterology, 1998
• Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users
  Alimentary Pharmacology & Therapeutics, 1998
• Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs
  Gut, 1997
• Prevalence of Helicobacter pylori infection and related gastroduodenal lesions in spouses of Helicobacter pylori positive patients with duodenal ulcer.
  Gut, 1996
• Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
  Archives of internal medicine (1960), 1996
• Prevention of Peptic Ulcer and Dyspeptic Symptoms with Omeprazole in Patients Receiving Continuous Non-Steroidal Anti-Inflammatory Drug Therapy: A Nordic Multicentre Study
  Scandinavian Journal of Gastroenterology, 1996
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease
  JAMA, 1994